Items where authors include "Hoffmann, L"

Article

Møller, DS, Lutz, CM, Khalil, AA et al. (8 more authors) (2022) Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy. Radiotherapy and Oncology. ISSN 0167-8140

Hindley, NP, Wright, CJ, Gadian, AM orcid.org/0000-0001-9890-403X et al. (9 more authors) (2021) Stratospheric gravity waves over the mountainous island of South Georgia: testing a high-resolution dynamical model with 3-D satellite observations and radiosondes. Atmospheric Chemistry and Physics, 21 (10). pp. 7695-7722. ISSN 1680-7316

Moller, DS, Nielsen, TB, Brink, C et al. (14 more authors) (2017) Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study. Radiotherapy and Oncology, 124 (2). pp. 311-317. ISSN 0167-8140

Wright, CJ, Hindley, NP, Hoffmann, L et al. (2 more authors) (2017) Exploring gravity wave characteristics in 3-D using a novel S-transform technique: AIRS/Aqua measurements over the Southern Andes and Drake Passage. Atmospheric Chemistry and Physics, 17 (13). pp. 8553-8575. ISSN 1680-7316

Proceedings Paper

Persson, G, Schytte, T, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2019) Locally advanced NSCLC: performance status based eligibility for adjuvant check point inhibitor. In: Radiotherapy and Oncology. ESTRO 38, 26-30 Apr 2019, Milan, Italy. Elsevier , S739-S740.

Nielsen, TB, Brink, C, Moeller, DS et al. (10 more authors) (2016) EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S916-S917.

Moeller, DS, Hoffmann, L, Lutz, CM et al. (10 more authors) (2016) OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2019, Turin, Italy. Elsevier , S259-S259.